Advocate Group’s Clorox CLX Stock Holding History

Advocate Group’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.44M	Buy	46,532 +19,871	+75%	+$1.91M	0.67%	61
2026 Q1	$2.76M	Buy	+26,661	New	+$3.02M	0.43%	66

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Advocate Group's CLX Position: Q2 2026 in Review

Advocate Group increased its Clorox (CLX) stake by 75% in Q2 2026, buying an estimated $1.91M and bringing the position to 46,532 shares worth $4.44M. The position accounts for 0.67% of the portfolio, ranked #61.

Advocate Group first reported a position in CLX in Q1 2026 and has held it in 2 quarters since. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Advocate Group held 46,532 shares of Clorox worth $4.44M as of Q2 2026.
Advocate Group bought 19,871 Clorox shares in Q2 2026, an estimated $1.91M.
Clorox made up 0.67% of Advocate Group's portfolio in Q2 2026, its #61 holding.
Advocate Group first reported a position in Clorox in Q1 2026 and has held it in 2 quarters since.
1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.